I concur with both yourself and biotechcatalyst. My thoughts about the veil of secrecy is that possibly the formulations are being analysed and improved as the trial progresses. If too much information is released before the final results are available, it may present a misleading picture of its success. Admitedly this does not explain why the company cannot announce whether ph 1 is now complete or not, and I will raise it at the AGM too. See you there!
The company has its finger in a number of pies and I would have thought there was news from other areas besides DEP that they could announce to an information starved audience.
Phase 1 Expansion, page-31
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.90M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.5¢ | 10.0¢ | $110.6K | 1.006M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 83046 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |